14-day Premium Trial Subscription Sign Up For FreeGet Free

ChemoCentryx Stock Forecast NASDAQ:CCXI

$36.15 (3.20%)

Volume: 1M

Closed: Dec 07, 2021

Hollow Logo Score: -3.824

ChemoCentryx Stock Forecast

$36.15 (3.20%)

Volume: 1M

Closed: Dec 07, 2021

Score Hollow Logo -3.824
* StockInvest.us uses dynamically calculated RSI max/min levels to determine when stock is oversold or overbought based on historical behavior.
RSImin/max Values: [ 25 - 75 ] RSI14 is 40 and the stock is currently not being overbought or oversold

Green day on Tuesday for ChemoCentryx stock after gaining 3.2%
(Updated on Dec 07, 2021)


Sell candidate since 2021-12-03 Gain 4.30%

The ChemoCentryx stock price gained 3.20% on the last trading day (Tuesday, 7th Dec 2021), rising from $35.03 to $36.15. , and has now gained 3 days in a row. It will be exciting to see whether it manages to continue gaining or take a minor break for the next few days. During the day the stock fluctuated 4.70% from a day low at $35.55 to a day high of $37.22. The price has been going up and down for this period, and there has been a -6.54% loss for the last 2 weeks. Volume has increased on the last day along with the price, which is a positive technical sign, and, in total, 59 thousand more shares were traded than the day before. In total, 1 million shares were bought and sold for approximately $40.63 million.

The stock lies in the lower part of a very wide and strong rising trend in the short term, and this may normally pose a very good buying opportunity. If the lower trend floor at $35.46 is broken, it will firstly indicate a slower rate of rising, but may also be an early warning for a trend shift. Given the current short-term trend, the stock is expected to rise 89.24% during the next 3 months and, with a 90% probability hold a price between $67.11 and $109.40 at the end of this 3-month period.

Signals & Forecast

There are mixed signals in the stock today. The ChemoCentryx stock holds a buy signal from the short-term moving average; at the same time, however, the long-term average holds a general sell signal. Since the longterm average is above the short-term average there is a general sell signal in the stock giving a more negative forecast for the stock. On further gains, the stock will meet resistance from the long-term moving average at $37.00. On a fall, the stock will find some support from the short-term average at $35.94. A break-up through the long-term average will give another buy signal, while a fall below the short-term average will add another sell signal and strengthen the general signal. A sell signal was issued from a pivot top point on Monday, October 11, 2021, and so far it has fallen -10.74%. Further fall is indicated until a new bottom pivot has been found. Furthermore, there is currently a sell signal from the 3 month Moving Average Convergence Divergence (MACD). Volume is rising along with the price. This is considered to be a good technical signal.

Support, Risk & Stop-loss

ChemoCentryx finds support from accumulated volume at $36.00 and this level may hold a buying opportunity as an upwards reaction can be expected when the support is being tested.

This stock has average movements during the day and with good trading volume, the risk is considered to be medium. During the last day, the stock moved $1.67 between high and low, or 4.70%. For the last week, the stock has had a daily average volatility of 7.99%.

Our recommended stop-loss: We hold an negative evaluation for this stock. No stop-loss is set.

Is ChemoCentryx stock A Buy?

ChemoCentryx holds several negative signals and we believe that it will still perform weakly in the next couple of days or weeks. We, therefore, hold a negative evaluation of this stock.

Current score: -3.824

Predicted Opening Price for ChemoCentryx of Wednesday, December 8, 2021

The predicted opening price is based on yesterday's movements between high, low, and the closing price.

Fair opening price December 8, 2021 Current price
$36.31 $36.15 (Undervalued)
Sell Candidate Unchanged

Remember To Visit Our YouTube Channel

Analyst Ratings

On Nov 10, 2021 "Raymond James" gave "$107.00 - $110.00" rating for CCXI. The price target was set to $38.86+2.2%.

Volatility and Risk
Daily Average Volatility: 7.99 %
Overall Risk: Very High High Medium Low Very Low
Volatility
7.99 %
Daily Average Volatility
Overall Risk

Very High
High
Medium
Low
Very Low

Support & Resistance

Resistance: $36.91
Price: $36.15
Support: $36.00

CCXI Insider Trading Show all Trades

INSIDER POWER

0.161

Last 100 transactions
Buy: 690 759 | Sell: 4 296 520 (Shares)
Date Action Amount Person Type
Dec 01, 2021 Sell 6 988 Schall Thomas J. Stock Option (right to buy)
Dec 01, 2021 Buy 6 988 Schall Thomas J. Common Stock
Dec 01, 2021 Buy 38 948 Schall Thomas J. Common Stock
Oct 12, 2021 Sell 4 000 000 Vifor (international) Ltd Common Stock, par value $0.001 per share
Oct 05, 2021 Buy 45 000 Jain Rita Stock Option (right to buy)
Show all Insider Trades
INSIDER POWER

0.161

Last 100 transactions
Buy: 690 759 | Sell: 4 296 520 (Shares)

Fibonacci Support & Resistance Levels

Level Price Change
Resistance 37.98 5.05 %
37.34 3.29 %
36.94 2.20 %
Current price: 36.15
Support 35.67 -1.33 %
35.27 -2.42 %
34.64 -4.19 %

Accumulated Volume Support & Resistance Levels

Level Price Chg %
Resistance 40.50 12.03 %
38.41 6.25 %
36.91 2.10 %
Current price 36.15
Support 36.00 -0.41%
34.47 -4.65%
32.43 -10.29%

Click to get the best stock tips daily for free!

About ChemoCentryx

ChemoCentryx ChemoCentryx, Inc., a clinical-stage biopharmaceutical company, focuses on the discovery, development, and commercialization of orally administered therapeutics to treat orphan and rare diseases, autoimmune diseases, inflammatory disorders, and cancer in the United States. Its lead drug candidates in clinical development include CCX168, which is in Phase II clinical trials for the treatment of orphan and rare diseases; CCX872, which is in Phase I... Read more

Golden Star Signal

This unique signal uses moving averages and adds special requirements that convert the very good Golden Cross into a Golden Star.

This signal is rare and, in most cases, gives substantial returns. From 10 000+ stocks usually only a few will trigger a Golden Star Signal per day!

Get access to Golden Star list now!

StockInvest.usJoin 100 000+ Happy Subscribers

Don't miss out on the runners!

Get The StockInvest.Us Newsletter

StockInvest.usStock Podcast

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE

ROCKIT